Gilead’s Kite nabs Carl June spinout Tmunity after neurotox kills patients, forcing reorg — and a rethink

One of the pioneers of first-gen CAR T has now swooped in to buy a second-gen cell therapy player with some stellar scientific ties, impressive early responses and a clinical record that includes a high-profile blowup in the clinic that killed several patients.

Gilead sub Kite is putting out word...

Click to view original post